STAT9h
AbbVie’s stumble, Amgen’s tumble, and more election fallout
On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...
Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...
Q3 2024 RLX Technology Inc Earnings Call
Thank you for standing by for RLX Technology Inc.'s third-quarter 2024 earnings conference call. (Operator Instructions) Today's conference call is being recorded and is expected to last for about 40 ...
Yahoo Finance8h
Early Warning Press Release - Nuvei completes its going private transaction
MONTRÉAL, Nov. 15, 2024 /CNW/ - This press release is being disseminated as required by Regulation 62-103 respecting the Early Warning System and Related Take-Over Bid and Insider Reporting Issues ...
Halozyme Therapeutics, Inc.: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team SAN ...
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.